no statement of use filed
on 29 Aug 2022
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
88300321 filed on 13th Feb 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia Read More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
No 88300321
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
29th Aug 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
29th Aug 2022 | ABANDONMENT - NO USE STATEMENT FILED |
05th Jan 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
04th Jan 2022 | SOU EXTENSION 5 GRANTED |
03rd Jan 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
07th Dec 2021 | SOU EXTENSION 5 FILED |
07th Dec 2021 | TEAS EXTENSION RECEIVED |
16th Jun 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Jun 2021 | SOU EXTENSION 4 GRANTED |
14th Jun 2021 | SOU EXTENSION 4 FILED |